Page 98 - Revista 2019

Revista de la Asociación Colombiana de Ciencias Biológicas
issn impreso 0120-4173, issn en línea 2500-7459

61. Siddique S, Tariq K, Rafi q S, Raheem A, Ahmed R, Shabbir-Moosajee M, et al. (2016) Sporadic Early
Onset Colorectal Cancer in Pakistan: A Case- Control Analysis of Microsatellite Instability. Asian Pac
J Cancer Prev.;17(5):2587-92.
62. Shia J, Klimstra DS, Nafa K, Offi t K, Guillem JG, Markowitz AJ, et al. (2005) Value of immunohis-
tochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary
colorectal neoplasms. Am J Surg Pathol.;29(1):96-104.
63. Becouarn Y, Rullier A, Gorry P, Smith D, Richard-Molard B, Echinard E, et al. (2005) Value of mi-
crosatellite instability typing in detecting hereditary non-polyposis colorectal cancer. A prospective
multicentric study by the Association Aquitaine Gastro. Gastroenterol Clin Biol. 29(6-7):667-75.
64. Shia J. (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal
cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of
immunohistochemistry. J Mol Diagn. 10(4):293-300.
65. Shia J, Tang LH, Vakiani E, Guillem JG, Stadler ZK, Soslow RA, et al. (2009) Immunohistochemistry
as fi rst-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis co-
lorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg
Pathol. 33(11):1639-45.
66. Niessen RC, Berends MJ, Wu Y, Sijmons RH, Hollema H, Ligtenberg MJ, et al. (2006) Identifi cation of
mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple
tumours associated with hereditary non-polyposis colorectal cancer. Gut. 55(12):1781-8.
67. Hendriks Y, Franken P, Dierssen JW, De Leeuw W, Wijnen J, Dreef E, et al. (2003) Conventional and
tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorec-
tal tumors. Am J Pathol.;162(2):469-77.
68. Luevano-Gonzalez A, Guzman AQ, Ancer Rodriguez J, Ortiz Lopez R, Rojas Martinez A, Gonzalez
Guerrero JF, et al. (2011) Analysis of DNA mismatch repair proteins expression and BRAF V600E
mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico. Arch Med Res.
42(6):457-62.
69. Waldmann E, Ferlitsch M, Binder N, Sellner F, Karner J, Heinisch B, et al. (2015) Tumor and Pa-
tient Characteristics of Individuals with Mismatch Repair Defi cient Colorectal Cancer. Digestion.
91(4):286-93.
70. Sekal M, Ameurtesse H, Chbani L, Ouldim K, Bennis S, Abkari M, et al. (2015) Epigenetics could
explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway
exploration. Diagn Pathol.;10:77.
71. Colling R, Church DN, Carmichael J, Murphy L, East J, Risby P, et al. (2015) Screening for Lynch
syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry
testing: an audit and cost analysis. J Clin Pathol. 68(12):1036-9.
72. South CD, Yearsley M, Martin E, Arnold M, Frankel W, Hampel H. (2009) Immunohistochemistry
staining for the mismatch repair proteins in the clinical care of patients with colorectal cancer. Genet
med. 11(11):812-7.
73. Sawada T, Yamamoto E, Yamano HO, Nojima M, Harada T, Maruyama R, et al. (2016) Assessment of
epigenetic alterations in early colorectal lesions containing BRAF mutations. Oncotarget. 7(23):35106-
18.
74. Bae JM, Kim JH, Kang GH. (2016) Molecular Subtypes of Colorectal Cancer and Their Clinicopatho-
logic Features, With an emphasis on the serrated neoplasia pathway. Arch Pathol Lab Med. 140(5):406-
12.
75. Jia M, Gao X, Zhang Y, Hoffmeister M, Brenner H. (2016) Different defi nitions of CpG island me-
thylator phenotype and outcomes of colorectal cancer: a systematic review. Clin Epigenetics. 8:25.
76. Duraturo F, Liccardo R, Cavallo A, De Rosa M, Rossi GB, Izzo P. (2015) Multivariate analysis as a
method for evaluating the pathogenicity of novel genetic MLH1 variants in patients with colorectal
cancer and microsatellite instability. Int J Mol Med. 36(2):511-7.
77. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. (2005) Poor sur-
vival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res.
65(14):6063-9.

98
Rev. Asoc. Col. Cienc.(Col.), 2019; 31: 87-99